<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Mol Neuropsychiatry</journal-id>
<journal-id journal-id-type="iso-abbrev">Mol Neuropsychiatry</journal-id>
<journal-id journal-id-type="publisher-id">MNP</journal-id>
<journal-title-group>
<journal-title>Molecular Neuropsychiatry</journal-title>
</journal-title-group>
<issn pub-type="ppub">2296-9209</issn>
<issn pub-type="epub">2296-9179</issn>
<publisher>
<publisher-name>S. Karger AG</publisher-name>
<publisher-loc>Allschwilerstrasse 10, P.O. Box · Postfach · Case postale, CH-4009, Basel, Switzerland · Schweiz · Suisse, Phone: +41 61 306 11 11, Fax: +41 61 306 12 34, karger@karger.ch</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29998117</article-id>
<article-id pub-id-type="pmc">6032037</article-id>
<article-id pub-id-type="doi">10.1159/000488679</article-id>
<article-id pub-id-type="publisher-id">mnp-0004-0035</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Recent Advances in the Genetics of Schizophrenia</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Avramopoulos</surname>
<given-names>Dimitrios</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>b</sup>
</xref>
<xref ref-type="corresp" rid="cor1">*</xref>
</contrib>
</contrib-group>
<aff id="aff1"><sup>a</sup>Institute of Genetic Medicine, Johns Hopkins University, Baltimore, Maryland, USA</aff>
<aff id="aff2"><sup>b</sup>Department of Psychiatry, Johns Hopkins University, Baltimore, Maryland, USA</aff>
<author-notes>
<corresp id="cor1">*Dimitrios Avramopoulos, Johns Hopkins University, 733 N. Broadway, BRB-507, Baltimore, MD 21205 (USA), E-Mail <email>adimitr1@jhmi.edu</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<month>6</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>30</day>
<month>5</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>1</day>
<month>6</month>
<year>2019</year>
</pub-date>
<!-- PMC Release delay is 12 months and
						0 days and was based on the <pub-date
						pub-type="ppub"/>. -->
<volume>4</volume>
<issue>1</issue>
<fpage>35</fpage>
<lpage>51</lpage>
<history>
<date date-type="received">
<day>7</day>
<month>12</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>21</day>
<month>3</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2018 by S. Karger AG, Basel</copyright-statement>
<copyright-year>2018</copyright-year>
</permissions>
<abstract>
<p>The last decade brought tremendous progress in the field of schizophrenia genetics. As a result of extensive collaborations and multiple technological advances, we now recognize many types of genetic variants that increase the risk. These include large copy number variants, rare coding inherited and de novο variants, and over 100 loci harboring common risk variants. While the type and contribution to the risk vary among genetic variants, there is concordance in the functions of genes they implicate, such as those whose RNA binds the fragile X-related protein FMRP and members of the activity-regulated cytoskeletal complex involved in learning and memory. Gene expression studies add important information on the biology of the disease and recapitulate the same functional gene groups. Studies of alternative phenotypes help us widen our understanding of the genetic architecture of mental function and dysfunction, how diseases overlap not only with each other but also with non-disease phenotypes. The challenge is to apply this new knowledge to prevention and treatment and help patients. The data generated so far and emerging technologies, including new methods in cell engineering, offer significant promise that in the next decade we will unlock the translational potential of these significant discoveries.</p>
</abstract>
<kwd-group>
<title>Keywords</title>
<kwd>Copy number variation</kwd>
<kwd>de novo mutations</kwd>
<kwd>Gene expression</kwd>
<kwd>Transcriptome</kwd>
<kwd>Gene editing</kwd>
<kwd>Genome-wide association studies</kwd>
<kwd>Genetic variation</kwd>
<kwd>Psychosis</kwd>
<kwd>Endophenotypes</kwd>
</kwd-group>
<counts>
<fig-count count="1"></fig-count>
<table-count count="2"></table-count>
<ref-count count="180"></ref-count>
<page-count count="17"></page-count>
</counts>
</article-meta>
</front>
</article>
</pmc-articleset>